Drawing for DET

USPTO serial 79154385

DET

Reviewed by CopyMark Law Group

Reg. 4750163Status 404
Filing date
Status date
Registration date
Jun 9, 2015
Examiner
GALAN, MATTHEW
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael T. Olsen

Michael T. Olsen WINTHROP & WEINSTINE225 South Sixth StreetCapella Tower, Suite 3500MINNEAPOLIS, MN 55402

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of diabetes, arteriosclerosis, cancer, cancer metastasis, high blood pressure, skin disease, arthritis, asthma, and allergies; medical diagnostic reagents; clinical medical reagents for diagnostic purposes; diagnostic preparations for medical purposes; medical and veterinary diagnostic reagents for genetic testing of tissue samples; clinical medical reagents and medical diagnostic reagents comprising gene chips for use in clinical and medical diagnostic applications; medical diagnostic reagents used for diagnosing certain diseases by analyzing the patterns of gene expression with DNA chips and protein chips; medical and veterinary diagnostic reagent kits consisting primarily of gene and protein reagents for use in immunodiagnosis testing; clinical medical and veterinary reagents for genetic detection of food poisoning bacteria; chemical reagents for medical and veterinary purposes; medical diagnostic reagents for analytical medical purposes; medical diagnostic reagents for analyzing components of body fluids, blood and urine; medical diagnostic reagents for urine analysis; medical diagnostic reagents for blood analysis; medical diagnostic reagents for analyzing electrolyte in body fluid; medical diagnostic reagents for immunoassay analysis; medical diagnostic reagents for measuring glucose; medical diagnostic reagents for measuring glycohemoglobin; medical diagnostic reagents for measuring ammonia; medical diagnostic test strips for urine analysis; medical diagnostic test strips for blood analysisSECTION 71 - CANCELLED—
009Laboratory devices for genetic testing, namely, for detecting genetic sequences; electronic products for the analysis of optical signals, namely, optical analyzers; electronic downloadable publications in the nature of slide shows in the field of medical education; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluidsSECTION 71 - CANCELLED—
010Medical apparatus and instruments, namely, medical diagnostic instruments for the analysis of body fluids and parts therefor; blood analyzers for medical diagnostic purposes and parts therefor; automated analyzers for detecting biochemicals in patients for medical diagnostic purposes and parts therefor; urine diagnostic apparatus for the detection of diabetes and parts therefor; medical apparatus for measuring glycated hemoglobin and parts therefor; medical apparatus for diagnostic use, namely, apparatus for determining osmotic pressure in patient bodily fluids and parts therefor; blood gas analyzers for medical diagnostic purposes and parts therefor; medical apparatus for drawing blood samples; blood glucose meters and parts therefor; sensors for monitoring blood glucose level as part of blood glucose meters; medical apparatus for drawing blood, namely, puncture apparatus and parts for positioning of puncture; lancets; lancets for blood drawing; surgical apparatus and instruments for medical, dental, and veterinary use; veterinary apparatus and instruments, namely, veterinary diagnostic apparatus and instruments for detection of disease in the blood, urine, and other bodily fluids, namely, semen, saliva, sweat, bile, spinal fluids, and intracellular fluids; devices for monitoring blood glucose for medical purposes; carrying case specifically adapted for carrying diabetic supplies, namely, blood glucose meter, testing strips and also including insulin and other related apparatusSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 11, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 11, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 25, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 26, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 26, 2022INPCINVALIDATION PROCESSED—
Aug 24, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 24, 2021C71TCANCELLED SECTION 71—
Sep 24, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 24, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 24, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Sep 24, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 24, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 24, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 9, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 14, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 17, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 30, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 30, 2015FIMPFINAL DISPOSITION PROCESSED—
Sep 9, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 9, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 4, 2015GPNXNOTIFICATION PROCESSED BY IB—
Mar 24, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 24, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 18, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 18, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 4, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 13, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 12, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 12, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Feb 12, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 12, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 12, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 11, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 11, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 2, 2015ALIEASSIGNED TO LIE—
Jan 23, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 5, 2014RFNTREFUSAL PROCESSED BY IB—
Nov 20, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 20, 2014RFRRREFUSAL PROCESSED BY MPU—
Nov 19, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 18, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 18, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 12, 2014DOCKASSIGNED TO EXAMINER—
Nov 12, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 7, 2014LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 6, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance